Kaushik J. Dave Ph.D., MBA, President and Chief Executive Officer, hosted a call on to discuss recent progress and outline development plans for the Company's clinical stage products: Iomab-B and Actimab-A.
http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Actinium-Pharmaceuticals-Announces-Plans-For-Iomab/ArticleNewsFeed/Article/detail/828613?ref=25
http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Actinium-Pharmaceuticals-Announces-Plans-For-Iomab/ArticleNewsFeed/Article/detail/828613?ref=25
No comments:
Post a Comment